SCHEMBL879274

SCHEMBL879274

C1=CCC(c2ccc(N(c3ccc(-c4ccccc4)cc3)c3ccc(-c4ccc(N(c5ccc(-c6ccccc6)cc5)c5ccc(-c6ccccc6)cc5)cc4)cc3)cc2)C=C1

nearest known ligand 0.35

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 3/20 0.35
MAOB P27338 1/20 0.35
CYP1A2 P05177 2/20 0.32
CYP2C9 P11712 2/20 0.32
CYP2C19 P33261 2/20 0.32
KDM4E B2RXH2 1/20 0.32
ALDH1A1 P00352 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
MAPT P10636 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
NPC1 O15118 1/20 0.31
RAB9A P51151 1/20 0.31
MEN1 O00255 1/20 0.30
TP53 P04637 1/20 0.30
HPGD P15428 1/20 0.30
KMT2A Q03164 1/20 0.30
EPHX1 P07099 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22755852 1.00 KDM1A (0.35) KDM1AMAOBCYP1A2CYP2C9CYP2C19
SCHEMBL14067605 1.00 KDM1A (0.35) KDM1AMAOBCYP1A2CYP2C9CYP2C19
SCHEMBL20686440 0.98 ALDH1A1 (0.34) KDM1AMAOBCYP1A2CYP2C9CYP2C19
SCHEMBL20714278 0.98 ALDH1A1 (0.34) KDM1AMAOBCYP1A2CYP2C9CYP2C19
SCHEMBL16994133 0.98 ALDH1A1 (0.34) KDM1AMAOBCYP1A2CYP2C9CYP2C19
SCHEMBL16500713 0.98 ALDH1A1 (0.34) KDM1AMAOBCYP1A2CYP2C9CYP2C19
SCHEMBL18774190 0.98 ALDH1A1 (0.34) KDM1AMAOBCYP1A2CYP2C9CYP2C19
SCHEMBL19443921 0.98 ALDH1A1 (0.34) KDM1AMAOBCYP1A2CYP2C9CYP2C19
SCHEMBL18801444 0.96 KDM1A (0.33) KDM1AMAOB
SCHEMBL23544007 0.93 MAOB (0.35) KDM1AMAOBCYP2C19KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3995497-A1 ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE Canon Kabushiki Kaisha (JP) 2022-05-11 EP disclosed
EP-3301099-B1 PHOSPHORESCENT HOMOLEPTIC TRIS-[DEUTERATED-2-(2-PYRIDINYL)PHENYL]-IRIDIUM COMPLEXES FOR USE IN LIGHT-EMITTING DEVICES UNIVERSAL DISPLAY CORP (US) 2021-04-28 EP disclosed
WO-2020184369-A1 PYRROMETHENE METAL COMPLEX, PYRROMETHENE COMPOUND, LIGHT-EMITTING ELEMENT MATERIAL, LIGHT-EMITTING ELEMENT, DISPLAY DEVICE, AND ILLUMINATION DEVICE 東レ株式会社 2020-09-17 WO disclosed
EP-3335253-B1 MATERIALS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2019-08-21 EP disclosed
US-9444053-B2 Aromatic amine derivative and electroluminescence device using the same IDEMITSU KOSAN CO., LTD. (JP) 2016-09-13 US disclosed
US-20150372239-A1 AROMATIC AMINE DERIVATIVE AND ELECTROLUMINESCENCE DEVICE USING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2015-12-24 US disclosed
US-8940412-B2 Material for organic electroluminescent element, and organic electroluminescent element IDEMITSU KOSAN CO., LTD. (JP) 2015-01-27 US disclosed
US-8940412-B2 Material for organic electroluminescent element, and organic electroluminescent element IDEMITSU KOSAN CO., LTD. (JP) 2015-01-27 US disclosed
EP-2434559-A1 ORGANIC ELECTROLUMINESCENT ELEMENT Idemitsu Kosan Co., Ltd. (JP) 2012-03-28 EP disclosed
EP-2055700-A1 AROMATIC AMINE DERIVATIVES AND ORGANIC ELECTROLUMINESCENCE DEVICES USING THE SAME Idemitsu Kosan Co., Ltd. (JP) 2009-05-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150372239-A1 AROMATIC AMINE DERIVATIVE AND ELECTROLUMINESCENCE DEVICE USING THE SAME MAOA, SETD1A, EML4 KDM1A 108/4885MAOB 24/4885CYP1A2 958/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.